← Back to headlines
Moderna and BioNTech Shares Surge Amid Renewed Interest in mRNA Technology
Pharmaceutical stocks Moderna and BioNTech have seen significant price increases as investors reassess the commercial viability and pipeline strength of messenger RNA therapies beyond vaccines.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Bill Gates Warns AI Is Humanity’s Most Dangerous Tool, Urges Global Regulation
24m ago
Revolut Launches Euro-Pegged Stablecoin Amid Growing Digital Asset Competition
33m ago
Pro-Russian Hackers Claim Responsibility for Major Cyberattacks on Norway
54m ago
Cyberattack Disrupts Global Operations at Medical Device Maker Boston Scientific
1h ago